Skip to main content

CLC Bio Pockets Undisclosed Private Investment for Product Development

NEW YORK (GenomeWeb News) — Bioinformatics shop CLC Bio has received an undisclosed amount of new financial backing from several new private Danish investors, the company said today.
 
The new backers include Peter Bogild, Tom Nordin, and Thomas Bruno, who have a combined capital base of $200 million, the company said.
 
CLC Bio will use the funding to continue developing software for next-generation sequencing and to continue to enhance its current product line, company CEO Thomas Knudsen said.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.